Related Experiment Video
Updated: Jan 26, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Atrial Fibrillation: A Novel Risk Factor for No-Reflow Following Primary Percutaneous Coronary Intervention
Adnan Kaya1, Muhammed Keskin2, Mustafa Adem Tatlisu3
1Cardiology, Duzce University School of Medicine, Duzce, Turkey.
Insights
Atrial fibrillation (AF) is common in ST-segment elevation myocardial infarction (STEMI) patients. This study found AF independently predicts the no-reflow phenomenon after primary percutaneous coronary intervention, highlighting AF as a significant risk factor.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia in patients experiencing ST-segment elevation myocardial infarction (STEMI).
- The association between AF and the no-reflow (NR) phenomenon following primary percutaneous coronary intervention (pPCI) in STEMI patients remains under-investigated.
- Understanding this relationship is crucial for optimizing treatment strategies and patient outcomes.
Purpose of the Study:
- To investigate the association between atrial fibrillation (AF) and the no-reflow (NR) phenomenon in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI).
- To identify independent predictors of NR in this patient population.
Main Methods:
- Retrospective analysis of 2452 STEMI patients who underwent pPCI.
- Patients were categorized into AF (n=370) and No-AF (n=2095) groups.
- No-reflow was defined as a Thrombolysis In Myocardial Infarction (TIMI) flow grade <3 post-procedure. Multivariable logistic regression was employed.
Main Results:
- No-reflow rates were significantly higher in the AF group (29.1%) compared to the No-AF group (11.8%) (P < .001).
- Patients in the AF group were older, had higher rates of three-vessel disease, and lower left ventricular ejection fraction.
- Multivariable analysis identified AF as an independent predictor of NR (OR: 1.81, 95% CI: 1.63-2.04, P < .001), alongside age, Killip class, anterior MI, diabetes, CKD, stent length, and smoking.
Conclusions:
- Atrial fibrillation is a significant independent predictor of the no-reflow phenomenon in STEMI patients undergoing pPCI.
- The presence of AF may indicate a higher risk of impaired coronary blood flow post-intervention.
- These findings underscore the importance of considering AF as a critical risk factor influencing outcomes in STEMI management.
Abstract:
There is a lack of evidence regarding the association of atrial fibrillation (AF) and no-reflow (NR) phenomenon in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (pPCI). A total of 2452 patients with STEMI who underwent pPCI were retrospectively investigated. After exclusions, 370 (14.6%) patients were in the AF group and 2095 (85.4%) were in the No-AF group. Patients with a thrombolysis in myocardial infarction flow rate <3 were defined as having NR. Patients in the AF group were older and had higher 3-vessel disease rates (24.1% vs 18.9%; P = .021) and lower left ventricular ejection fraction (45.4 [11.7] vs 48.7 [10.5%]; P < .001). No-reflow rates were higher in the AF group than in the No-AF group (29.1% vs 11.8%; P < .001). According to multivariable analysis, AF (odds ratio: 1.81, 95% confidence interval: 1.63-2.04, P < .001), age, Killip class, anterior myocardial infarction, diabetes mellitus, chronic kidney disease, stent length, and smoking were independent predictors of NR following pPCI. Atrial fibrillation is a quite common arrhythmia in patients with STEMI. Atrial fibrillation was found to be an independent predictor of NR in the current study. This effect of AF on coronary flow rate might be considered as an important risk factor in STEMI.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Nursing Interventions I: Taxonomy of Nursing Interventions
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Nursing Interventions II: Selecting and Classifying the Nursing Interventions

